de Groot, S., Charehbili, A., van Laarhoven, H. W. M., Mooyaart, A. L., Dekker-Ensink, N. G., van de Ven, S., . . . Kroep, J. R. (2016). Insulin-like growth factor 1 receptor expression and IGF1R 3129G > T polymorphism are associated with response to neoadjuvant chemotherapy in breast cancer patients: Results from the NEOZOTAC trial (BOOG 2010-01). Breast Cancer Res.
Citación estilo Chicagode Groot, Stefanie, et al. "Insulin-like Growth Factor 1 Receptor Expression and IGF1R 3129G > T Polymorphism Are Associated With Response to Neoadjuvant Chemotherapy in Breast Cancer Patients: Results From the NEOZOTAC Trial (BOOG 2010-01)." Breast Cancer Res 2016.
Cita MLAde Groot, Stefanie, et al. "Insulin-like Growth Factor 1 Receptor Expression and IGF1R 3129G > T Polymorphism Are Associated With Response to Neoadjuvant Chemotherapy in Breast Cancer Patients: Results From the NEOZOTAC Trial (BOOG 2010-01)." Breast Cancer Res 2016.